
doi: 10.1111/tbj.12352
pmid: 25413630
Breast cancer is the most common cancer in women with 232,670 new cases estimated in the USA for 2014. Approaches for reducing breast cancer risk include lifestyle modification, chemoprevention, and prophylactic surgery. Lifestyle modification has a variety of health benefits with few associated risks and is appropriate for all women regardless of breast cancer risk. Chemoprevention options have expanded rapidly, but most are directed at estrogen receptor positive breast cancer and uptake is low. Prophylactic surgery introduces significant additional risks of its own and is generally reserved for the highest risk women.
Selective Estrogen Receptor Modulators, Aromatase Inhibitors, Health Behavior, Antineoplastic Agents, Breast Neoplasms, Prophylactic Surgical Procedures, Chemoprevention, Risk Assessment, Tamoxifen, Risk Factors, Humans, Female, Life Style, Mastectomy
Selective Estrogen Receptor Modulators, Aromatase Inhibitors, Health Behavior, Antineoplastic Agents, Breast Neoplasms, Prophylactic Surgical Procedures, Chemoprevention, Risk Assessment, Tamoxifen, Risk Factors, Humans, Female, Life Style, Mastectomy
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 12 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
